Multi-vial Discount Available
Get notified when this batch is released
Enter your email and we'll let you know as soon as this product is available again.
Research Use Only · Not for human or veterinary consumption.
People also purchased
5mg · $43.00
5mg · $29.00
10mg · $43.00
Safety Data Sheet
In the 16-section GHS format covering identification, hazards, handling, storage and disposal.
- Next batch coming soon
- Quality Guaranteed
- Cold-Chain Shipping
- Free US Shipping Over $150
What is Cerebrolysin?
Cerebrolysin is not a single peptide. It is a mixture made by using enzymes to break down purified protein from pig brain, leaving a blend of short peptides and free amino acids. Because it is a mixture rather than one molecule, it has no single chain, no single weight and no chemical formula, and two batches are not guaranteed to contain exactly the same blend. It has been tested in cells, in mice, and in people after an interruption of blood flow to the brain.
Product information reviewed by Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer · Reviewed
Cerebrolysin Research & Reference
What Cerebrolysin does in published studies, and how to work with it in the laboratory, are covered in full on two dedicated pages rather than summarised here, so neither the evidence nor the handling detail is cut short.
Technical Specs
Labeled quantity is net peptide content, not gross salt weight.
Frequently Asked Questions
Is Cerebrolysin third-party tested for purity?+−
Yes. Every batch of Cerebrolysin is tested by an independent third-party laboratory using HPLC and MS-UPLC, confirming purity and mass identity before the batch is released. Pure Peptides does not test its own material.
What does "Research Use Only" mean?+−
It means Cerebrolysin is supplied for in-vitro laboratory research and for no other purpose, and must not be administered to humans or animals. Cerebrolysin is legal to purchase in the United States for in vitro and non-clinical laboratory research. It carries no FDA approval or approved use in the United States. Cerebrolysin holds national marketing authorisation in Austria and several other countries, where EVER Neuro Pharma GmbH is listed as the marketing authorisation holder, for indications including stroke, traumatic brain injury and dementia. Cerebrolysin is not a scheduled substance under the Controlled Substances Act. Sold strictly for qualified research use, not human or veterinary administration.
How is Cerebrolysin shipped and stored?+−
Cerebrolysin ships from US stock with cold-chain packaging and full tracking; orders placed before noon EST on business days are typically dispatched the same business day. On arrival, store the lyophilized powder at -20°C or below, dry and protected from light.
Why does this product have no sequence, molecular weight or molecular formula?+−
Cerebrolysin is a preparation rather than a synthesized peptide. It is made by using enzymes to break down purified porcine brain protein, leaving a mixture of short peptides and free amino acids, so no single sequence, molecular weight or molecular formula describes it. It does carry a CAS registry number, 12656-61-0, which identifies the preparation itself rather than a single molecule. Its identity comes from its source material and manufacturing process. Batch-to-batch composition is not guaranteed to be identical.
What do the clinical trials show?+−
A 2023 systematic review pooled seven randomized trials in 1,773 participants after acute ischemic stroke. One of those trials tested Cortexin, a Cerebrolysin-like agent, so the all-cause death result covers the mixed set of Cerebrolysin or Cortexin: probably little to no difference, from six trials in 1,689 participants, at moderate-certainty evidence. The increase in the number of people experiencing non-fatal serious adverse events comes from three trials of Cerebrolysin in 1,335 participants, also at moderate-certainty evidence. None of the included trials reported functional outcome, quality of life or early death. The Cerebrolysin research article gives the figures.
Cognitive & Neuropeptide Research
Related Compounds
>99%
>99%
>99%
>99%
Reviewed for scientific accuracy
Dr. Martina Rossi, PhD
PhD, Université Grenoble Alpes · Scientific Contributor and Reviewer
Dr. Rossi's doctoral research at Université Grenoble Alpes examined the vascular functions of bone morphogenetic proteins. Her peer-reviewed work spans cell and molecular biology, vascular biology, and gene therapy, in journals including Cardiovascular Research, Scientific Reports, and Brain Sciences. She reviews Pure Peptides' product, reference, and research pages for scientific accuracy against the sources they cite.